Anti-Androgen Receptor antibody [ER179(2)] - ChIP Grade (Ab108341)
DHTR, NR3C4, AR, Androgen receptor, Dihydrotestosterone receptor, Nuclear receptor subfamily 3 group C member 4
详细信息
背景信息
Anti-Androgen Receptor antibody [ER179(2)] - ChIP Grade (ab108341) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in ChIC/CUT&RUN-seq, ChIP, ICC/IF, IHC-P, WB in human, mouse, rat samples. Anti-Androgen Receptor antibody [ER179(2)] - ChIP Grade (ab108341) has been cited over 79 times in peer reviewed journals and is trusted by the scientific community. Abcams high quality manufacturing and validation processes ensure Anti-Androgen Receptor antibody [ER179(2)] - ChIP Grade (ab108341) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility. Anti-Androgen Receptor antibody [ER179(2)] - ChIP Grade (ab108341) has 4 independent reviews from customers. Anti-Androgen Receptor antibody [ER179(2)] - ChIP Grade (ab108341) specifically detects Androgen Receptor (UniProt ID: P10275; Molecular weight: 99kDa) and is sold in 100 uL and 1 mL selling sizes. Conjugation-ready, carrier free format available for antibody clone ER179(2) - ab212175. Antibody clone ER179(2) is also available pre-conjugated to a variety of labels for your convenience - HRP, Alexa Fluor® 647, Alexa Fluor® 488, Alexa Fluor® 594 ( ab22352, ab22432, ab2269, ab26358). The androgen receptor (AR)/DHTR plays a crucial role in the development and progression of various cancers, including breast cancer and prostate cancer. Utilizing our highly-validated AR antibody, can significantly enhance the detection and study of AR expression. Research indicates that AR is a promising therapeutic target for treating hormone-dependent cancers, offering potential for improved patient outcomes. Validated also for CUT&RUN, which is a key applications to map protein-DNA interactions on a genome-wide scale using NGS. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies.
文献引用 (117)
The Histone Methyltransferase KMT2D Is a Critical Mediator of Lineage Plasticity and Therapeutic Response in Castration-Resistant Prostate Cancer.
组蛋白甲基转移酶 KMT2D 是去势抵抗性前列腺癌谱系可塑性和治疗反应的关键介质。
Lactate derived from cancer-associated fibroblasts promotes alternative splicing and castration resistance in prostate cancer.
源自癌症相关成纤维细胞的乳酸可促进前列腺癌的选择性剪接和去势抵抗。
ERRγ impedes neuroendocrine prostate cancer development.
ERRγ 会阻碍神经内分泌前列腺癌的发展。
Targeting Tumor Microenvironment-Derived NRG1-HER2/3 Signaling with Zenocutuzumab Restores Sensitivity to AR Inhibition in PTEN Wild-type Prostate Cancer.
利用 Zenocutuzumab 靶向肿瘤微环境衍生的 NRG1-HER2/3 信号通路,可恢复 PTEN 野生型前列腺癌对 AR 抑制剂的敏感性。
Clinical significance of YAP and androgen receptor expression in osteosarcoma: Evidence from a retrospective cohort study.
YAP 和雄激素受体表达在骨肉瘤中的临床意义:一项回顾性队列研究的证据。
Divergent FOXA1 mutations drive prostate tumorigenesis and therapy-resistant cellular plasticity.
FOXA1 基因突变导致前列腺肿瘤发生和细胞耐药性
Circular RMST cooperates with lineage-driving transcription factors to govern neuroendocrine transdifferentiation.
环状RMST与谱系驱动转录因子协同作用,调控神经内分泌转分化。
CD36-mediated endocytosis of proteolysis-targeting chimeras.
CD36介导的靶向蛋白水解嵌合体的内吞作用
Androgen receptor promotes arachidonic acid metabolism and angiogenic microenvironment in AFP-negative hepatocellular carcinoma.
雄激素受体促进 AFP 阴性肝细胞癌中的花生四烯酸代谢和血管生成微环境
AR+TREM2+ macrophage induced pathogenic immunosuppression promotes prostate cancer progression
AR+TREM2+巨噬细胞诱导的病理性免疫抑制促进前列腺癌进展
- 1
- 2
- 3
- 4
- 5
- 6
- 12